Abstract
As a pathological product of bovine gallbladder, natural Calculus Bovis (CB) has a long history in Traditional Chinese Medicine to treat many diseases such as: stroke,coma, delirium, epilepsy, encephalitis B, etc. Experimental studies showed that natural CB had effects on central nervous system, cardiovascular system, inflammation, etc. Recent analyses confirmed that bilirubin composed the main proportion of all CB components. Preclinical researches demonstrated that bilirubin had ischemia protection, antiinflammation, anti-cancer, anti-virus, erythropoiesis, anti-pyretic, immune function protection, and cardiovascular effects. Mechanism investigations indicated bilirubin as a powerful antioxidant. Bilirubin also inhibited inflammatory factors and complement. Here, we suggest bilirubin may account for many effects of CB, and has potential therapeutic prospects.
Keywords: Antioxidant, bilirubin, biliverdin, heme oxygenase, natural Calculus Bovis, therapeutic.
Current Signal Transduction Therapy
Title:Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Volume: 11 Issue: 1
Author(s): Jijun Chen, Aiqin Wang and Qingqi Chen
Affiliation:
Keywords: Antioxidant, bilirubin, biliverdin, heme oxygenase, natural Calculus Bovis, therapeutic.
Abstract: As a pathological product of bovine gallbladder, natural Calculus Bovis (CB) has a long history in Traditional Chinese Medicine to treat many diseases such as: stroke,coma, delirium, epilepsy, encephalitis B, etc. Experimental studies showed that natural CB had effects on central nervous system, cardiovascular system, inflammation, etc. Recent analyses confirmed that bilirubin composed the main proportion of all CB components. Preclinical researches demonstrated that bilirubin had ischemia protection, antiinflammation, anti-cancer, anti-virus, erythropoiesis, anti-pyretic, immune function protection, and cardiovascular effects. Mechanism investigations indicated bilirubin as a powerful antioxidant. Bilirubin also inhibited inflammatory factors and complement. Here, we suggest bilirubin may account for many effects of CB, and has potential therapeutic prospects.
Export Options
About this article
Cite this article as:
Chen Jijun, Wang Aiqin and Chen Qingqi, Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis, Current Signal Transduction Therapy 2016; 11 (1) . https://dx.doi.org/10.2174/1574362411666160407212127
DOI https://dx.doi.org/10.2174/1574362411666160407212127 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Agaricus blazei Water Extracts as Alternative Medicines
Current Pharmaceutical Analysis Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis
Current Pharmaceutical Design Neuroleptic Malignant Syndrome: A Pilot Study on Psychiatric Inpatients in Iran
Current Psychopharmacology Drugs Targeting Parasite Lysosomes
Current Pharmaceutical Design Computational Drug Repositioning by Target Hopping: A Use Case in Chagas Disease
Current Pharmaceutical Design Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Conformations and Assembly of Amyloid Oligomers by Electrospray Ionisation - Ion Mobility Spectrometry - Mass Spectrometry
Current Analytical Chemistry Molecular Mechanisms Determining Opposed Functional States of Microglia
Current Neuropharmacology Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod
Current Drug Targets The Gut Mucosa as a Site for Induction of Regulatory T-Cells
Current Pharmaceutical Design Protein Conformational Diseases: From Mechanisms to Drug Designs
Current Drug Discovery Technologies Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry Formulation and Application of Biodegradable Nanoparticles Based Biopharmaceutical Delivery - An Efficient Delivery System
Current Pharmaceutical Design Gene Therapy in the Anterior Eye Segment
Current Gene Therapy Immunoglobulin Free Light Chains in Immune Responses
Current Immunology Reviews (Discontinued) Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: The Monocyte/Macrophage in the Pathogenesis of AIDS: The Next Frontier for Therapeutic Intervention in the CNS and Beyond: Part I)
Current HIV Research Thinking Outside the Brain: Immunorregulation in Multiple Sclerosis
Current Immunology Reviews (Discontinued) Identification of Peptide Binders to Truncated Recombinant Chikungunya Virus Envelope Protein 2 Using Phage Display Technology and Their <i>In Silico</i> Characterization
Protein & Peptide Letters